Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21CA069253-01
Application #
2113336
Study Section
Special Emphasis Panel (ZRG3-ET-1 (01))
Project Start
1996-05-01
Project End
1998-04-30
Budget Start
1996-05-01
Budget End
1997-04-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Thomas Jefferson University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107

  Publications

Mastrangelo, Michael J; Lattime, Edmund C (2002) Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors. Cancer Gene Ther 9:1013-21
Mastrangelo, M J; Eisenlohr, L C; Gomella, L et al. (2000) Poxvirus vectors: orphaned and underappreciated. J Clin Invest 105:1031-4
Mastrangelo, M J; Maguire Jr, H C; Eisenlohr, L C et al. (1999) Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma. Cancer Gene Ther 6:409-22
Mastrangelo, M J; Sato, T; Lattime, E C et al. (1998) Cellular vaccine therapies for cancer. Cancer Treat Res 94:35-50
Mastrangelo, M J; Maguire Jr, H C; Sato, T et al. (1996) Active specific immunization in the treatment of patients with melanoma. Semin Oncol 23:773-81